ArriVent BioPharma Stock Forecast - Simple Regression

AVBP Stock   19.62  0.02  0.10%   
The Simple Regression forecasted value of ArriVent BioPharma Common on the next trading day is expected to be 22.57 with a mean absolute deviation of 1.39 and the sum of the absolute errors of 84.62. ArriVent Stock Forecast is based on your current time horizon. Although ArriVent BioPharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of ArriVent BioPharma's systematic risk associated with finding meaningful patterns of ArriVent BioPharma fundamentals over time.
As of today the rsi of ArriVent BioPharma's share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of ArriVent BioPharma's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with ArriVent BioPharma Common, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting ArriVent BioPharma's stock price prediction:
EPS Estimate Next Quarter
(0.79)
EPS Estimate Current Year
(4.29)
EPS Estimate Next Year
(3.91)
Wall Street Target Price
40.2333
EPS Estimate Current Quarter
(0.78)
Using ArriVent BioPharma hype-based prediction, you can estimate the value of ArriVent BioPharma Common from the perspective of ArriVent BioPharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards ArriVent BioPharma using ArriVent BioPharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards ArriVent using crowd psychology based on the activity and movement of ArriVent BioPharma's stock price.

ArriVent BioPharma Implied Volatility

    
  2.68  
ArriVent BioPharma's implied volatility exposes the market's sentiment of ArriVent BioPharma Common stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ArriVent BioPharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ArriVent BioPharma stock will not fluctuate a lot when ArriVent BioPharma's options are near their expiration.
The Simple Regression forecasted value of ArriVent BioPharma Common on the next trading day is expected to be 22.57 with a mean absolute deviation of 1.39 and the sum of the absolute errors of 84.62.

ArriVent BioPharma after-hype prediction price

    
  USD 19.67  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of ArriVent BioPharma to cross-verify your projections.
At this time, ArriVent BioPharma's Other Current Liabilities is relatively stable compared to the past year. As of 01/08/2026, Cash is likely to grow to about 117 M, while Total Stockholder Equity is likely to drop slightly above 171.8 M.

Open Interest Against 2026-04-17 ArriVent Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast ArriVent BioPharma's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in ArriVent BioPharma's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for ArriVent BioPharma stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current ArriVent BioPharma's open interest, investors have to compare it to ArriVent BioPharma's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of ArriVent BioPharma is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in ArriVent. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

ArriVent BioPharma Additional Predictive Modules

Most predictive techniques to examine ArriVent price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ArriVent using various technical indicators. When you analyze ArriVent charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Simple Regression model is a single variable regression model that attempts to put a straight line through ArriVent BioPharma price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

ArriVent BioPharma Simple Regression Price Forecast For the 9th of January

Given 90 days horizon, the Simple Regression forecasted value of ArriVent BioPharma Common on the next trading day is expected to be 22.57 with a mean absolute deviation of 1.39, mean absolute percentage error of 2.98, and the sum of the absolute errors of 84.62.
Please note that although there have been many attempts to predict ArriVent Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that ArriVent BioPharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

ArriVent BioPharma Stock Forecast Pattern

Backtest ArriVent BioPharmaArriVent BioPharma Price PredictionBuy or Sell Advice 

ArriVent BioPharma Forecasted Value

In the context of forecasting ArriVent BioPharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. ArriVent BioPharma's downside and upside margins for the forecasting period are 18.98 and 26.16, respectively. We have considered ArriVent BioPharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
19.62
22.57
Expected Value
26.16
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of ArriVent BioPharma stock data series using in forecasting. Note that when a statistical model is used to represent ArriVent BioPharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria119.2009
BiasArithmetic mean of the errors None
MADMean absolute deviation1.3872
MAPEMean absolute percentage error0.0659
SAESum of the absolute errors84.6189
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as ArriVent BioPharma Common historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for ArriVent BioPharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ArriVent BioPharma Common. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
16.0519.6723.29
Details
Intrinsic
Valuation
LowRealHigh
17.7124.2027.82
Details
7 Analysts
Consensus
LowTargetHigh
36.6140.2344.66
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.21-1.07-0.74
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as ArriVent BioPharma. Your research has to be compared to or analyzed against ArriVent BioPharma's peers to derive any actionable benefits. When done correctly, ArriVent BioPharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in ArriVent BioPharma Common.

Other Forecasting Options for ArriVent BioPharma

For every potential investor in ArriVent, whether a beginner or expert, ArriVent BioPharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ArriVent Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ArriVent. Basic forecasting techniques help filter out the noise by identifying ArriVent BioPharma's price trends.

ArriVent BioPharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ArriVent BioPharma stock to make a market-neutral strategy. Peer analysis of ArriVent BioPharma could also be used in its relative valuation, which is a method of valuing ArriVent BioPharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

ArriVent BioPharma Common Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of ArriVent BioPharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of ArriVent BioPharma's current price.

ArriVent BioPharma Market Strength Events

Market strength indicators help investors to evaluate how ArriVent BioPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ArriVent BioPharma shares will generate the highest return on investment. By undertsting and applying ArriVent BioPharma stock market strength indicators, traders can identify ArriVent BioPharma Common entry and exit signals to maximize returns.

ArriVent BioPharma Risk Indicators

The analysis of ArriVent BioPharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ArriVent BioPharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting arrivent stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with ArriVent BioPharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ArriVent BioPharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma will appreciate offsetting losses from the drop in the long position's value.

Moving against ArriVent Stock

  0.59MSFT MicrosoftPairCorr
  0.52PG Procter GamblePairCorr
  0.51CVX Chevron CorpPairCorr
  0.51GE GE AerospacePairCorr
  0.5HD Home DepotPairCorr
The ability to find closely correlated positions to ArriVent BioPharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ArriVent BioPharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ArriVent BioPharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ArriVent BioPharma Common to buy it.
The correlation of ArriVent BioPharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ArriVent BioPharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ArriVent BioPharma Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ArriVent BioPharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for ArriVent Stock Analysis

When running ArriVent BioPharma's price analysis, check to measure ArriVent BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ArriVent BioPharma is operating at the current time. Most of ArriVent BioPharma's value examination focuses on studying past and present price action to predict the probability of ArriVent BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ArriVent BioPharma's price. Additionally, you may evaluate how the addition of ArriVent BioPharma to your portfolios can decrease your overall portfolio volatility.